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1. Introduction 
Lumbar spinal arthroplasty was first reported in clinical settings more than 10 years ago by 
Griffith et al 1. This early experience was acquired with the first lumbar artificial disc, the 
CHARITÉ I, in patients with degenerative disc disease. Since that time, a randomized 
controlled trial comparing arthroplasty with the CHARITÉ Artificial Disc vs. anterior 
lumbar interbody fusion with the BAK Cage and iliac crest bone was completed. Multiple 
other lumbar arthroplasty devices have been developed subsequent to the CHARITÉ and 
are undergoing or completing clinical trials.  
Unlike other spinal medical devices, lumbar discs are required by the Food and Drug 
Administration to complete randomized controlled trials (RCT) prior to market approval in 
the United States. As a result, lumbar arthroplasty devices have undergone more scrutiny 
and clinical evaluation than any other spinal medical devices. Specifically, a new device, the 
ProDisc-L, was granted FDA approval in 2006 and was described in a recent peer-review 
publication2. In addition, the Maverick Total Disc Arthroplasty System (Medtronic Sofamor 
Danek), Kineflex Lumbar Disc (SpinalMotion), and FlexiCore Intervertebral Disc 
(SpineCore/Stryker) lumbar discs have both completed their randomized enrollments and 
are currently in continued access (non-randomized) mode. 
All these ongoing and completed randomized clinical trials have generated a large body of 
evidence on the safety and efficacy of arthroplasty for lumbar spine in clinical applications 
and, in many cases, in Level-1 publications. 
The safety and efficacy of arthroplasty are not the only parameters discussed in the >60 
clinical papers published over the last 6 years. In fact, significant insights were developed in 
the impact of arthroplasty on sagittal alignment and motion, possible adverse events and 
reoperation, as well as optimal patient selection and indication. Surgical technique and 
health economics papers have also been generated in an effort to fully understand the 
clinical and societal impact of this new technology. This review paper is aimed at providing 
an overview of all the existing clinical data related to spinal arthroplasty. 
2. Materials and methods 
A search was conducted on the OVID and COCHRANE Library database to collect all 
clinical data relevant to spinal arthroplasty. Specifically, the following keywords were used: 
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(CHARITÉ Artificial Disc or ProDisc-L or Maverick Total Disc Arthroplasty System or 
KineFlex or FlexiCore Intervertebral Disc) and (disc) and (lumbar). The search was limited 
to English-language papers. Preclinical, biomechanical, and review papers were excluded 
from the final paper selection. In addition, papers describing obsolete devices (CHARITÉ I 
and CHARITÉ II) were also excluded from the study. A total of 60 papers were analyzed 
herein and subdivided by key topic, as following: 1) General clinical outcomes; 2) 
Radiographic Analysis: Range of motion, heterotopic ossification and sagittal balance 
analyses; 3) facet and adjacent-level degeneration; 4) Revisions and revision strategies; 5) 
Surgical technique; 6) Complications; 7) Special patient population analyses; and 8) Health 
economics evaluations. 
3. Results 
3.1 General clinical outcome results 
General clinical outcome results were available for the CHARITÉ Artificial Disc, the 
ProDisc-L, the Maverick Total Disc Arthroplasty System, and the FlexiCore Intervertebral 
Disc. However, level-1 data was only available for the CHARITÉ Artificial disc and the 
ProDisc-L, as the final study FDA IDE results for the Maverick Total Disc Arthroplasty 
System and the FlexiCore Intervertebral Disc have yet to be published. 
The CHARITÉ Artificial Disc manuscripts described clinical outcomes as early as 1 year 3 
and up to 13 years post-operative4. The short/medium term papers included herein 
typically disclosed early analyses from single sites involved in the CHARITÉ Artificial Disc 
IDE study comparing arthroplasty with CHARITÉ Artificial Disc vs. anterior interbody 
fusion with BAK cage and autograft 3, 5, 6. The complete RCT at 2-year follow-up included 
205 arthroplasty and 99 fusion patients, and was thoroughly described in two manuscripts, 
one focused on clinical outcomes7, the other on radiographic outcomes8. Three additional 
medium- and long-term studies were also found: 2 papers with 10-year follow-up 4, 9 and 
one with an average of 6.6 year follow-up 10.  
Safety and efficacy of arthroplasty was demonstrated in all short- and medium-term studies. 
Specifically, at 2-years post-operative, Blumenthal and McAfee reported no device-related 
complications and a reoperation rate of 5.4% (vs. 9.1% in the control arm). Efficacy was also 
demonstrated using validated disability (ODI) and pain (VAS) clinical outcomes tools. At 2 
years, the reduction in ODI reached 48.5% (vs. 42.4% in the control group) and the absolute 
reduction in VAS reached 40.6 points (vs. 34.1 points in the control group) 7, 8. 
Two of the three long-term studies confirmed these findings. Lemaire et al reported 10-
year follow-up results in 100 patients. 4 This study included 54 patients operated at one 
level, 45 patients operated at two levels and one patient operated at 3 levels. Overall, 
authors reported excellent or good clinical outcomes in 90% cases. In a second long-term 
study, David et al presented 10-year data on 106 patients9. Only one-level surgeries were 
performed in this study. Excellent or good clinical outcome was obtained in 82.1% 
patients. Both papers thus concluded that arthroplasty was a viable option for disc 
degeneration.  
Recently, a third, medium-term paper was published by Ross et al, describing the long-
term effect of arthroplasty in 160 patients (226 CHARITÉ Artificial Discs). This paper 
reported a cumulative survival rate at 156 months of 35% and a mean ODI score 
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improvement of 14%. Implant removal was also described in 12 patients10. These 
relatively poor findings were further discussed in two Letters to the Editors, which 
pointed out mathematical inconsistencies and overall clinical flaws in the manuscript, and 
further highlighted the need of proper surgical technique and patient selection for optimal 
clinical outcome 11, 12.  
The ProDisc-L manuscripts described clinical outcomes as early as 3 months13 and up to 
8.7 years post-operative 14. As described above for CHARITÉ Artificial Disc, The short-
term papers typically disclosed early findings from one or two of the sites that 
participated in the randomized controlled trial comparing ProDisc-L against a 360 degree 
fusion13, 15-21. The complete RCT at 2-year follow-up included 161 arthroplasty and 75 
fusion patients 2. The long-term data included 64 patients operated at one site, of which 55 
were available between 7 and 11 years post-operative, for clinical and radiographic 
follow-up14. All these studies concluded similarly that disc arthroplasty, at all evaluated 
time points, was safe and resulted in complication and/or re-operation rates comparable 
to those generally accepted for spinal surgery (complication rate of 9% at 8.7 years14; there 
were no major complications, but a reoperation rate of 3.7% at 2 years was reported2). In 
addition to safety, efficacy of spinal arthroplasty was also shown herein as all cases 
presented significant improvements in pain and disability. The final RCT data reported 
improvements in the arthroplasty group in Visual Analogue Scores (VAS) for pain by an 
average 39-mm, and in disability, as determined by the Oswestry Disability Index (ODI), 
by 28 points. It is worth noting, however, that the ODI tool utilized in this RCT was not 
the validated and widely accepted ODI methodology Version 1.0 as defined by Fairbanks 
et al22. In a Letter to the Editor, Fairbanks denounced the use of the so-called Oswestry 
Disability Index in the ProDisc-L study and thus cast doubt on the validity of the 
disability improvement outcomes observed herein23.  
The 2 clinical data publications on the MAVERICK device were both based on the same data 
set of 64 patients, collected at one site24, 25. The clinical outcomes were described using the 
ODI Version 1.0 and VAS scores. The efficacy of arthroplasty was once again demonstrated 
using these tools, as ODI scores decreased by an average of 20.7 points and VAS scores by 
4.4 points. As for the FlexiCore Intervertebral Disc, only one paper was recently published26. 
This manuscript describes the clinical outcomes of 44 patients, of which only 6 were 
available for 2-year follow-up. While the clinical relevance of this data may therefore be 
questionable, authors still concluded that the device may be safe and efficacious but that the 
data was not representative of the entire patient cohort. 
3.2 Radiographic analyses: Range of motion, heterotopic ossification and sagittal 
balance analyses 
Radiographic evaluations such as ROM, heterotopic ossification, and sagittal balance have 
been broadly analyzed for the CHARITÉ Artificial Disc, the ProDisc-L, as well as the 
Maverick Total Disc Arthroplasty System.  
Unlike other clinical and radiographic outcomes, accurate measurement of ROM was shown 
to be challenging and, to some extent, subjective, as patient positioning, imaging staff 
training, and other factors unrelated to the actual motion potential of the spine were shown 
to impact final readings 27. Using ProDisc-L cases, Lim et al evaluated different 
methodologies and associated error margins for the measurement of ROM from 
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radiographic images. Specifically, Lim et al concluded that a ROM of at least 4.6 degs must 
be observed in order to be 95% certain that a given device had any sagittal motion at all. 
Similarly, changes needed to be at least 9.6 degs in ROM in order to confirm at 95% that 
change in motion really happened28, 29. These technical limitations might explain the 
inconsistent ROM data, particularly for ProDisc-L cases, found in the published literature. 
The flexion-extension ROM results from the 2-year RCT were determined at 7.7 degrees and 
4.67 degrees and characterized as a normal ROM 2. However, at 8.7 years post-operative, 
Huang et al reported a ROM less than that reported in asymptomatic normal individuals, 
with an average motion of 3.8 degs 30. In a 2006 prospective study on 41 patients with 2 year 
follow-up, Leivseth et al also reported that the device fails to restore normal segmental 
motion, while another retrospective study on 26 patients concluded that sagittal balance and 
ROM significantly improved after lumbar arthroplasty31.  
Less controversy was observed when reviewing ROM data for the CHARITÉ Artificial 
Disc. A complete manuscript was dedicated to the radiographic data of the 2-year RCT of 
the CHARITÉ Artificial Disc 8. In this study, arthroplasty patients had a 13.6% increase in 
motion from preoperative to the 2-year post-operative time point. The ROM also 
correlated to device placement, as poor device placement resulted in a statistically 
significant reduction in motion. At 10-year follow-up, David reported an average 10.1 
degs ROM, a value very similar to the 10.3 degs reported by Lemaire et al in their 10-year 
follow-up study4, 9.  
Le Huec et al published the only data available on radiographic findings after 
arthroplasty with the Maverick Total Disc Arthroplasty System. In their study, Le Huec et 
al broadened their analysis to include sagittal alignment and pelvic tilt24, 32. Using data 
related to 35 patients at an average 14 months post-operative, authors showed 
maintenance of overall lordosis and unchanged sacral and pelvic tilts, following 
arthroplasty.  
More recently, a study by Tournier comparing all three - CHARITÉ Artificial Disc, 
ProDisc-L and Maverick Total Disc Arthroplasty System - further refined the analyses 
from LeHuec on pelvic and sagittal tilt. In this study, authors found no difference in 
ROM between prostheses and observed maintenance of sagittal balance before and after 
surgery with all devices. However, modifications of the lumbar curvature were 
observed33.  
The issue of heterotopic ossification in clinical cases of lumbar arthroplasty has been 
presented by McAfee et al and, more recently, by Tortolani et al34, 35. In his 2003 paper, 
McAfee introduced a novel method to characterize spinal heterotopic ossification. This 
methodology was applied by Tortolani et al in reviewing the 276 arthroplasty patients from 
the CHARITÉ Artificial Disc RCT (randomized and non-randomized cases). From this 
analysis, 4.3% cases of heterotopic ossification were noted. However, heterotopic ossification 
was not related to range of motion, as the authors concluded that no difference in the range 
of motionat 24-months post-operatively was found between the patients who had and those 
who did not have heterotopic ossification.  
3.3 Facets and adjacent-level degeneration 
Facet degeneration is currently a contraindication for arthroplasty. However, a few 
publications have investigated the impact of arthroplasty on index-level facet joints, as 
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well as adjacent-level discs, in order to determine whether the added motion at the index 
level could slow down the natural progression of the disease at the facets and the 
adjacent-level joints. 
Three long-term analyses evaluated adjacent-level degeneration, one with ProDisc-L at 8.7 
years, and the other two with the CHARITÉ Artificial Disc at 10 years follow-up. In the 
ProDisc-L study, 24% cases developed adjacent level degeneration by the latest follow-up 
time point. A correlation was also found between a low range of motion and the 
prevalence of adjacent level degeneration: all patients with adjacent-level degeneration 
had a ROM l ess than 5 degrees, while only 59% of patients without adjacent-level 
degeneration had a ROM less than 5 degrees 36. Lemaire et al and David reported 2 (2%) 
and 3 (2.8%) cases of adjacent-level degeneration at the latest time point, respectively4, 9. 
Lemaire et al and David also disclosed 11 cases (11%) and 5 cases (4.7%) with facet 
arthrosis at the latest time point, respectively. 
The issue of facet degeneration was also recently discussed in a short-term study. From a 13-
patient case series with 12 months follow-up, Trouillier et al alluded to possible 
maintenance of facet joint integrity following arthroplasty with CHARITÉ Artificial Disc 
based on the favorable results from their series37. At the other end of the spectrum, Shim et 
al, at the 3-year time point, observed 36.4% and 32.0% increase in index-level facet 
degeneration and 19.4% and 28.6% adjacent level disc degeneration with the CHARITÉ 
Artificial Disc and the ProDisc-L, respectively.  
3.4 Revision and revision strategies 
The issue of possible revisability of arthroplasty devices represented a key concern when the 
first artificial disc, the CHARITÉ Artificial Disc, was introduced to the market. As such, 
multiple papers have focused on this issue and provided surgical and clinical insights to 
ensure appropriate approaches to revision surgery.  
The first description of appropriate revision for a CHARITÉ Artificial Disc was presented 
by David38. In this single-case example, a CHARITÉ Artificial Disc was replaced at 9.5 
years post-operative with another CHARITÉ Artificial Disc. The author concluded that 
revision of the disc with another disc could be safely and adequately performed and was 
thus an alternative to a revision fusion procedure. David also noted that, due to the 
inherent difficulty of an anterior approach, only experienced surgeons should undertake 
this operation. Further revision and explantation of the disc were also described by 
McAfee et al and Leary et al 39, 40. McAfee et al confirmed Davids experience and 
concluded that arthroplasty with the CHARITÉ Artificial Disc did not preclude any 
further procedures at the index level during primary insertion, with nearly one third 
being revisable to a new motion-preserving prosthesis and just over two thirds being 
successfully converted to ALIF and/or posterior pedicle screw arthrodesis, the original 
alternative procedure. Leary further implied that technical errors in position and sizing of 
the implant were largely to blame for further revision surgery. Finally, Punt et al 
reviewed 75 revision cases from the Dutch experience (estimated by the authors at 
approximately more than 1000 Dutch patients). In this series, patients were fused 
posteriorly either with removal of the disc or without removal of the disc. No statistically 
significant difference was observed between these 2 groups41. This paper included 
patients previously described by Van Ooij et al42.  
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3.5 Surgical technique 
The appropriate surgical technique with the CHARITÉ Artificial Disc as well as the ProDisc-
L was presented in 2 separate publications. Geisler et al provided a detailed account of the 
surgical technique for the CHARITÉ Artificial Disc, and dedicated an entire section of the 
paper to patient selection and preoperative planning, two critical aspects of successful spinal 
arthroplasty43. Authors also strongly recommended the availability of a spinal access 
surgeon to perform the approach, especially in revision cases. Finally, appropriate midline 
identification and positioning of the device also represented a critical discussion point in 
this paper. For the ProDisc-L, Gumbs et al retrospectively reviewed 64 cases of open 
retroperitoneal exposures and concluded that the approach was safe and, as discussed by 
Geisler et al, required a multidisciplinary team, such as an orthopedic and an access or 
general surgeon, to minimize complication rates44.  
3.6 Complications 
Complications from spinal arthroplasty have also been reported for all three devices. Most 
complications requiring revision surgery were resolved by either fusion and/or disc 
replacement surgery. Interestingly, the causes of these complications seemed to be device-
specific (i.e.; due to the design and/or make of the device). 
For the ProDisc-L, the major complication described in the literature referred to the vertical 
split fracture of the vertebral body following total disc replacement. This occurrence was 
described by Shim et al in 2 separate cases that were not revised or treated surgically, but 
experienced prolonged back pain as a result45. An additional complication in the form of 
acquired spondylolysis was described by Schulte et al46. Authors attributed this 
complication to inaccurate implant size and positioning.  
For the CHARITÉ Artificial Disc, the key complications were observed on the earlier 
devices, which were gamma sterilized in air and thus had a potential for oxidation of the 
core polyethylene nucleus 38. Complications due to this oxidation process were described by 
Van Ooij et al (and Punt et al, as this paper reiterate data from the Van Ooij patient 
population)41, 42. This issue was resolved with a process change in 1998 to gamma 
sterilization in nitrogen. In a review of the RCT patient population, Geisler et al also 
evaluated the rate of neurological complications in the arthroplasty group vs. fusion group. 
The rate of neurological complication was described as exceedingly low in both groups with 
no statistically significant differences between groups.  
While little has been published so far on the Maverick Total Disc Arthroplasty System, one 
article described an early removal of the Maverick Total Disc Arthroplasty System 47. This 
removal was performed one year after implantation due to severe persistent back pain. 
Intraoperatively, gross metallosis around the articulation of the device was observed. The 
revision was successful and included a 360 degs fusion. Metallosis was thus cited as a 
potential complication for devices consisting of a metal-on-metal design. Zeh et al presented 
an additional potential complication: due to this metal-on-metal structure of the Maverick 
Total Disc Arthroplasty System, cobalt and chromium ions from the device were being 
released into the bloodstream 48. In this study, cobalt and chromium ions from subjects 
implanted with the Maverick Total Disc Arthroplasty System were evaluated and compared 
to ion levels in total hip arthroplasty (THA) patients. Zeh et al found that concentrations of 
Cr/Co measured in the serum were similar in terms of their level to the values measured in 
THA metal-on-metal combinations or exceed those values reported in the literature. As a 
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result, while Zeh et al did not recommend holding back with the implantation of the device, 
they did suggest long-term clinical evaluations to determine the clinical impact of high ion 
levels in serum and also recommended discussions with patients on the potential health 
effects of the prosthesis. 
3.7 Special patient population analyses  
The clinical outcomes for selective patient populations (e.g.; smokers, >60yr old) were 
discussed in multiple papers, more specifically for the ProDisc-L device. Bertagnoli et al 
lead these efforts with 4 publications presenting clinical data on arthroplasty with ProDisc-L 
in patients with: 1) single-level arthroplasty15; 2) multi-level arthroplasty16; 3) patients 60-
years or older49; 4) smokers 50; and 5) arthroplasty cases adjacent to a fused level 51. While 
Bertagnoli et al repeatedly stated the importance of proper patient selection in each and 
every paper, all the results presented in these studies concluded that spinal arthroplasty 
with ProDisc-L successfully addressed low-back pain in these specific patient populations. 
Hannibal et al recently compared one- vs. two-level arthroplasty cases at the 2-year follow-
up to try and establish whether one-level cases were experiencing greater clinical 
improvements as compared to the two-level cases. This hypothesis was not verified as 
differences in clinical improvements between one- and two-level cases were marginal 52. 
Yaszay et al approached the problem from a different angle and evaluated patients 
outcomes based on a radiographic observation, i.e.; preoperative disc height 53. Yaszay et al 
observed that patients with greater disc collapse experienced a greater benefit from total 
disc replacement, as compared to patients with less collapsed intervertebral discs. On 
average, patients in all of Bertagnoli et al and Yaszay et al series showed significant clinical 
improvement following arthroplasty.  
Using the CHARITÉ Artificial Disc IDE RCT patient population, sub-analyses by patient 
types were also published by Guyer et al and Geisler et al. Specifically, patients were 
stratified by age at surgery (18-45 vs. 46-60) or whether they had had prior surgery or 
not54, 55. In both cases, there was no difference in clinical outcome between groups, 
whether patients were 18-45 or 46-60, or whether patient did or did not have prior 
surgery. Along the same trend, Geisler et al also evaluated the clinical outcomes of those 
patients from the CHARITÉ Artificial Disc RCT that did not improve with arthroplasty 
and needed revision surgery to a fusion. These patients (7.1% of all arthroplasty cases) did 
not improve, despite the revision surgery, further highlighting the importance of proper 
patient selection, and possibly, the fact that patient selection still remains a somewhat 
approximate science(59)56.  
3.8 Health economics evaluations 
The impact of spinal arthroplasty on health care economics were reviewed for both the 
CHARITÉ Artificial Disc and the ProDisc-L. Guyer et al analyzed the costs related to a 
CHARITÉ Artificial Disc arthroplasty compared to: 1) an anterior fusion with autograft: 2) 
anterior fusion with rhBMP-2 (Infuse Bone Graft and LT-Cages) as well as 3) instrumented 
posterior lumbar interbody fusion. This analysis included the cost of revision surgery at the 
rate estimated in the published literature. Guyer et al concluded that all fusion procedures 
were more costly than the arthroscopy approach by 12.0% (ALIF with autograft) to 36.5% 
(ALIF with rhBMP-2 and posterior fusion)57.  
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A similar analysis by Levin et al evaluated the costs of 1- and 2-level arthroplasty vs. 360 
degs fusion. This study did not include possible needs for revisions. Nevertheless, one-level 
arthroplasty cases were found to be less costly than one-level fusions ($35,592 for 
arthroplasty vs. $46,280 for 360 deg fusion) while two-level cases were similar for both 
groups ($55,524 for arthroplasty vs. $56,823 for fusion)58.  
4. Discussion 
From 2002 to 2008, a significant volume of data was made available on the clinical impact of 
arthroplasty. Sixty studies related to the clinical use of arthroplasty were published in peer-
reviewed papers, of which 35 described data collected prospectively and 18 represented 
data from multi-center studies. The total number of patients described in the literature for 
spinal arthroplasty is difficult to evaluate, since many studies are early data releases or sub-
analyses of the main randomized controlled trials performed for each new device. Thus, a 
given patient population might have been discussed in multiple papers. Overall, however, it 
was estimated that approximately 1,600 patients were included in the current literature.  
The RCTs for the ProDisc-L and the CHARITÉ Artificial Disc both demonstrated the non-
inferiority of the arthroplasty procedure, compared to their respective controls (ALIF for 
CHARITÉ Artificial Disc, 360 degs fusion for ProDisc-L. The complete RCT data for 
Maverick Total Disc Arthroplasty System and FlexiCore Intervertebral Disc are not yet 
published.) For some specific clinical outcomes such as pain, disability, and hospital stay, 
arthroplasty patients experienced greater clinical outcomes at some of the follow-up time 
points. For the CHARITÉ Artificial Disc RCT, arthroplasty patients fared statistically better 
than fusion on pain and disability for all but the 24-month follow-up time point. Hospital 
stay was also significantly shorter in the CHARITÉ Artificial Disc group as compared to the 
fusion group. As for ProDisc-L, pain scores were statistically better in the investigational 
cohort as compared to control. In addition, most other case series, for any of the given 
arthroplasty products, including those with short- and long-term follow-up data, presented 
favorable overall outcomes for spinal lumbar arthroplasty.  
The issues of range of motion, heterotopic ossification, and sagittal balance have also drawn 
significant attention. While accurate and reproducible measurement of the lumbar ROM 
may be a significant limitation to collect meaningful data, average ROM at the 2-year time 
point throughout the studies evaluated herein were at ~ 7-10 degs. In addition, restoration 
of sagittal balance was observed for each device, the CHARITÉ Artificial Disc, the ProDisc-L 
as well as the Maverick Total Disc Arthroplasty System.  
This review contained however somewhat contradictory data on the issue of facet and 
adjacent-level degeneration. While two of the 10year studies showed very small instances of 
facet and/or adjacent-level degeneration, others reported nearly a 1/3 of all cases with 
either CHARITÉ Artificial Disc or ProDisc-L developing changes in facet morphology. The 
inconsistency in these results points at potential surgeon-specific techniques and approaches 
that may impact the long-term benefits of both procedures.  
Surgeon-specific variability in technique and proficiency was also cited in cases of revision. 
In fact, a study by Regan et al evaluating the occurrence of revision in low-volume vs. high-
volume center, confirmed that surgeon in low-volume centers may incur greater peri-
operative complications, however none that affected long-term outcomes59. Nevertheless, 
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revisions were often found to be associated with technical errors, such as errors in 
positioning or sizing of the implant.  
This critical importance of proper technique was in fact described in the 2 technique papers 
discussed herein. Both these publications stressed the importance of proper patient 
selection, a recurrent theme in almost all arthroplasty discussions.  
Three types of major complications were described or foreseen in the current literature: 1) 
vertebral body split due to the ProDisc-L keel design; 2) oxidation of the core polymer 
nucleus, a problem specific to first generation CHARITÉ I prosthesis; and 3) metallosis and 
long-term impact of metal ions in the body. While the issue of metallosis and metal ions still 
needs to be thoroughly investigated, the problems related to vertebral body split only 
occurred once in the published literature, and as such, may represent a rare occurrence, and 
that of core oxidation, has been since resolved with new sterilization techniques following 
which core oxidation of the polymer nucleus is not observed. Thus, possible complications 
related to devices with metal-on-poly designs seem to be fairly limited. 
Finally, low rates of complication and adverse event were observed for most of all analyzed 
patients. For the ProDisc-L, smokers as well as patients 60 years of age seemed to experience 
similar benefit from the procedure. In all these studies, however, authors reiterated the 
importance of proper patient selection, thus concluding that, while all analyzed patient 
types experienced clinical benefit from the procedure, specific care must be given to only 
operate on appropriate patients.  
Finally, no technology is sustainable in today’s market place if its cost is prohibitive. Thus, 
the impact of arthroplasty on health economics was also investigated. Both, the CHARITÉ 
Artificial Disc and the ProDisc-L study came up at a lower cost than their fusion controls, 
whether potential revision costs were included or not. No data on cost exists yet for the 
Maverick Total Disc Arthroplasty System and the FlexiCore Intervertebral Disc. 
5. TDR surgery 
The typical diseased lumbar segment considered for artificial disc technologies at L4-L5 or 
L5-S1 has advanced degenerative disc disease with loss of vertical height and lordosis, 
dehydration changes, adjacent Modic endplate changes, and little motion on dynamic 
studies (see Figure 1). The natural progression of degenerative disease disc limits the joint 
mobility and this biomechanical fact places more forces on the adjacent levels then in the 
normal situation. The artificial lumbar disc, by restoring normal motion, height, and 
lordosis, will decrease the forces on the adjacent levels. Thus, theoretically, levels adjacent to 
a dynamically stabilized level may have beneficial effects compared to the natural history of 
the unoperated degenerative state. Clearly some patients will benefit from the decreased 
force on the adjacent vertebral level(s) following a dynamic stabilization (arthroplasty) 
compared to a static stabilization (fusion). Estimates of the rate and groups of patients at 
maximum benefit will need to await long-term clinical follow up studies with lumbar 
arthroplasty devices similar to the hip and knee arthroplasty registries. Also, although a 
dynamically stabilized level can be converted to a fusion, a fused level cannot be converted 
to a dynamic joint. Thus, artificial technology can be thought of as a definitive procedure for 
the vast majority of patients that can be converted to a fusion if the pain and functional 
goals are not met or degenerative changes occur in the posterior elements and the 
arthrodesis level is believed to be the pain generator.  
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Fig. 1. Typical radiographies for a TDR patient. 1a. Pre-operative MRI. 1b. Post-operative A-
P radiography. 1c. Post-operative lateral radiography. 
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Fig. 2. Five years results from the Charité FDA IDE prospective randomized study. 2a. ODI. 
2b. VAS. 
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6. Revision techniques 
If a CHARITÉ artificial disc were required to be revised, there would be two options available. 
One approach would be anterior reoperation. This would involve dissecting the 
retroperitoneal area and dealing with the post-op scarring and hence increased risk of great 
vessel damage, ureteral damage, and damage to the sympathetic nerves compared to a case 
without prior dissection and scarring in the retroperitoneal space. A revision allows removal, 
position adjustment or size change of the CHARITÉ artificial disc. The plastic core would be 
removed first, and then the metal endplates are separated from the bony endplates by using a 
chisel between them and levering away from the bone into the disc space. This would allow 
the placement of another artificial disc in the disc space or the conversion to a fusion. 
Alternately, a posterior operation with rod-screw stabilization and posterior lateral fusion 
could be used to fuse the lumbar segment, which would use the CHARITÉ artificial disc as an 
anterior load share device. As with all surgical decision making, understanding the 
biomechanical reasoning and etiology of clinical failure is of the utmost importance. In patients 
with recurring or persistent pain the characterization of the pain generator is often more 
important than the exact surgical technique used. Radiologic studies such as dynamic A-P and 
Lat x-ray and multislice CT will aid in understanding failure of the device or progression of 
the degenerative anatomic changes. Radiologic and provocative studies, including 
discography, anesthetic or negative discography, nerve root blocks, epidural injections, and 
facet injections may all be utilized to identify the anatomic site of the pain generator. 
7. Long-term follow-up of TDR patients 
The initial CHARITÉ was planned with a 2-year follow-up period. At the request of the FDA 
the follow-up period was extended to 5-years and the sites requested to participate in the 
“new” 2 to 5 year follow-up period. Multiple sites did participate in this extended reporting 
period and formed the basis of the 5-year CHARITÉ results. The CHARITÉ 5-year ODI and 
VAS results (Figure 2a and 2b respectively) were substantially the same as the 2-years 
follow-up results60. Despite the prospective collection of the these results, critics formulated 
objections to these reported good results61. 
8. Conclusion 
Overall, there were only minor differences between devices in terms of overall clinical and 
radiographic outcome. Significant improvements in clinical outcomes were seen with all 
evaluated devices, regardless of make or design. An average maintenance of motion post-
operatively was described, along with relatively low rates of revision. Differences between 
devices were mostly apparent in complication types: one potential complication for devices 
with keels was vertebral body split, while devices with metal-on-metal designs could cause 
metallosis and ion release in the serum. As for metal-on-poly devices, degradation of the 
polymer core was also mentioned as a potential complication, albeit one that is not relevant 
for the current metal-on-poly devices. Specific emphasis was found in most of all 
publications on proper technique and patient selection, regardless of implant design. 
Finally, arthroplasty was found to be less costly than fusion.  
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